In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1661 News Items found
See Dr. Kojo Elenitoba-Johnson, the inaugural Chair of the MSK Department of Pathology and Laboratory Medicine.
Pinpoint Accuracy: How Dr. Elenitoba-Johnson Helps Lead the Diagnosis of Cancer at MSK

Learn about Dr. Kojo Elenitoba-Johnson, who leads teams of Memorial Sloan Kettering experts in interpreting lab tests and diagnosing cancer as the inaugural Chair of the MSK Department of Pathology and Laboratory Medicine. He is also a member in the Human Oncology and Pathogenesis Program.
An MSK scientist peers through a microscope
MSK Research Highlights, April 21, 2023

New MSK research finds adherence is a hurdle for home-based colorectal cancer tests; sheds new light on tumor-associated macrophages in glioblastoma; identifies statins as a promising addition to treatment for HER2-positive gastric cancer; and describes how a new single-cell transcriptome atlas opens the “black box” of early human embryo development.
Marie-Josée Kravis Quantitative Biology Fellows Corey Weistuch and Sneha Mitra
Quantitative Biology Fellowship Targets Cancer With Math and Computer Science

Learn about the Marie-Josée Kravis Fellowship in Quantitative Biology, a two-year postdoctoral fellowship that aims to build a new generation of skilled quantitative biologists who specialize in cancer.
Finding
Gloved hands hold a pipette over two bottles of pink solution.
The Gut Microbiome and Cancer: MSK Researchers Present New Findings

Research led by Josie Robertson Investigator Karuna Ganesh provided clues that microbiomes might explain the increase in colorectal cancer among younger patients.
MSK computational biologist Henry Walch
Why Is Colorectal Cancer in African Americans Hard To Treat? One Reason Is Genetics

African American patients with colorectal cancer are less likely to have tumors that respond well to newer treatments such as targeted therapy and immunotherapy.
MSK medical oncologist and bladder cancer specialist Jonathan Rosenberg
New Metastatic Bladder Cancer Therapy Approved by FDA: Enfortumab Vedotin (Padcev)

A powerful therapy called an antibody-drug conjugate is approved for more people with metastatic bladder cancer.
Mobile Health Unit
Education and Care on Wheels: MSK’s Mobile Health Unit Serves Communities across New York Metro Area

MSK’s Mobile Health Unit provides health education, screening, and navigation services to underserved communities in the New York metro area.
Cassidy Cobbs
Transgender Visibility: Meet MSK Cancer Research Staffer Cassidy Cobbs

Cassidy Cobbs is many things: a valued colleague who works at the Sloan Kettering Institute; a doting parent to a pit bull named Mando; a beloved sibling; and a passionate baseball fan, who memorized the stats of former player, Ryne Sandberg, at the age of 5. What Cassidy is not is someone who identifies as either a man or a woman.
Microscopy image showing a quiescent cluster of lung adenocarcinoma tumor cells with low STING expression.
MSK Scientists Identify Potential New Strategy Against Metastasis

A team of scientists at the Sloan Kettering Institute has identified the STING cellular signaling pathway as a key player in keeping dormant cancer cells from progressing into aggressive tumors months, or even years, after they’ve escaped from a primary tumor.
In the Clinic
Dr. Carol Aghajanian
For Advanced Endometrial Cancer, Chemotherapy Plus Immunotherapy Improves Outcomes

New research published in The New England Journal of Medicine finds adding the immunotherapy drug pembrolizumab (Keytruda®) to standard chemotherapy greatly improves outcomes in people with advanced endometrial cancer. The phase 3 study was overseen by MSK gynecologic medical oncologist Carol Aghajanian.